Cargando…

Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat

The 5HT1B receptor (5HT1BR) contributes to the pathogenic effects of serotonin in pulmonary arterial hypertension. Here, we determine the effect of a microRNA96 (miR96) mimic delivered directly to the lungs on development of severe pulmonary hypertension in rats. Female rats were dosed with sugen (3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Docherty, Craig K., Denver, Nina, Fisher, Simon, Nilsen, Margaret, Hillyard, Dianne, Openshaw, Rebecca L., Labazi, Hicham, MacLean, Margaret R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533346/ https://www.ncbi.nlm.nih.gov/pubmed/33230444 http://dx.doi.org/10.1016/j.omtn.2020.09.002

Ejemplares similares

Sex-Dependent Changes in Right Ventricular Gene Expression in Response to Pressure Overload in a Rat Model of Pulmonary Trunk Banding
por: Labazi, Hicham, et al.
Publicado: (2020)

Influence of 2‐Methoxyestradiol and Sex on Hypoxia‐Induced Pulmonary Hypertension and Hypoxia‐Inducible Factor‐1‐α
por: Docherty, Craig K., et al.
Publicado: (2019)

Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice
por: Labazi, Hicham, et al.
Publicado: (2021)

Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen–hypoxia rat model by cardiac magnetic resonance imaging
por: Jayasekera, Geeshath, et al.
Publicado: (2020)

Sugen, hypoxia and the lung circulation
por: Voelkel, Norbert F., et al.
Publicado: (2021)

Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension
por: Mair, Kirsty M., et al.
Publicado: (2019)

Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension
por: Philip, Nicolas, et al.
Publicado: (2023)

Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension
por: Al-Husseini, Aysar, et al.
Publicado: (2015)

Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents
por: Chen, Tianji, et al.
Publicado: (2022)

Sugen–morphine model of pulmonary arterial hypertension
por: Agarwal, Stuti, et al.
Publicado: (2020)

Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Bogaard, Harm J., et al.
Publicado: (2019)

IL‐33/ST2 receptor‐dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice
por: Indralingam, Cynthia S., et al.
Publicado: (2022)

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension
por: Link, Patrick A., et al.
Publicado: (2023)

Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2016)

The selective PGI(2) receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats
por: Honda, Yohei, et al.
Publicado: (2020)

Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways
por: Morris, Hannah E., et al.
Publicado: (2023)

Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
por: Tornling, Göran, et al.
Publicado: (2023)

Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia‐induced pulmonary hypertension
por: Neto‐Neves, Evandro M., et al.
Publicado: (2017)

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2019)

The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still “the One:” A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman
por: Bogaard, Harm J., et al.
Publicado: (2020)

Estrogen metabolites in a small cohort of patients with idiopathic pulmonary arterial hypertension
por: Denver, Nina, et al.
Publicado: (2020)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT
por: van der Have, Oscar, et al.
Publicado: (2022)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
por: Rodor, Julie, et al.
Publicado: (2023)

The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series)
por: MacLean, Margaret (Mandy) R.
Publicado: (2018)

Current strategies for quantification of estrogens in clinical research
por: Denver, Nina, et al.
Publicado: (2019)

Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females
por: Dempsie, Yvonne, et al.
Publicado: (2011)

MicroRNAs in pulmonary arterial remodeling
por: Grant, Jennifer S., et al.
Publicado: (2013)

Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Mediated Redox Signaling and Vascular Remodeling by 16α-Hydroxyestrone in Human Pulmonary Artery Cells: Implications in Pulmonary Arterial Hypertension
por: Hood, Katie Y., et al.
Publicado: (2016)

Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension
por: Mair, Kirsty M., et al.
Publicado: (2020)

Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension
por: Dempsie, Yvonne, et al.
Publicado: (2013)

Derivatization enhances analysis of estrogens and their bioactive metabolites in human plasma by liquid chromatography tandem mass spectrometry
por: Denver, Nina, et al.
Publicado: (2019)

MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension
por: Faight, Erin M., et al.
Publicado: (2017)

Data for analysis of catechol estrogen metabolites in human plasma by liquid chromatography tandem mass spectrometry
por: Denver, Nina, et al.
Publicado: (2019)

A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolism
por: MacLean, Margaret R., et al.
Publicado: (2022)

Oestrogen receptor alpha in pulmonary hypertension
por: Wright, Audrey F., et al.
Publicado: (2015)

Notch3 signalling and vascular remodelling in pulmonary arterial hypertension
por: Morris, Hannah E., et al.
Publicado: (2019)

Regulation of INSIG2 by microRNA-96
por: Jo, Youngah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k83llt8i7dqoeqpl68ue352hei